Pharmacokinetic Studies of Multiple Active Components in Rat Plasma Using LC-MS/MS after Oral Administration of Shaoyao-Gancao-Fuzi Decoction
Abstract Shaoyao-Gancao-Fuzi decoction, a famous traditional Chinese medicine prescription and composed of the roots of Paeonia lactiflora Pall., Paeoniaceae, Glycyrrhiza glabra L., Fabaceae, and Aconitum carmichaelii Debx., Ranunculaceae, exhibits an anti-inflammatory and analgesic effects. However, pharmacokinetic studies of its potential active ingredients have rarely been studied. The aim of present study was to characterize the pharmacokinetic properties of albiflorin, paeoniflorin, benzoylmesaconine, liquiritin, liquiritigenin, glycyrrhizic acid, and glycyrrhetinic acid after administration of the Shaoyao-Gancao-Fuzi decoction in rat. The plasma concentrations of the seven active components were analyzed by liquid chromatography coupled to mass spectrometry with a good accuracy (87.62–109.71%), precision (2.96–11.38%), extract recovery (85.79–103.68%), matrix effect (90.38–107.77%), and stability (86.66–112.75%). As results, albiflorin, paeoniflorin, and benzoylmesaconine were rapidly absorbed with Tmax < 1 h and slowly eliminated with mean half-life of 6.22–7.11 h. Glycyrrhetinic acid exhibited a high bioavailability. Graphical abstract.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:30 |
---|---|
Enthalten in: |
Revista Brasileira de farmacognosia - 30(2020), 6 vom: Dez., Seite 810-817 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Lin, Li [VerfasserIn] |
---|
Links: |
Volltext [lizenzpflichtig] |
---|
Themen: |
Benzoylmesaconine |
---|
doi: |
10.1007/s43450-020-00119-0 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
SPR042811759 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | SPR042811759 | ||
003 | DE-627 | ||
005 | 20230519094319.0 | ||
007 | cr uuu---uuuuu | ||
008 | 210122s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1007/s43450-020-00119-0 |2 doi | |
035 | |a (DE-627)SPR042811759 | ||
035 | |a (DE-599)SPRs43450-020-00119-0-e | ||
035 | |a (SPR)s43450-020-00119-0-e | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | 4 | |a 610 |q ASE |
100 | 1 | |a Lin, Li |e verfasserin |4 aut | |
245 | 1 | 0 | |a Pharmacokinetic Studies of Multiple Active Components in Rat Plasma Using LC-MS/MS after Oral Administration of Shaoyao-Gancao-Fuzi Decoction |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
520 | |a Abstract Shaoyao-Gancao-Fuzi decoction, a famous traditional Chinese medicine prescription and composed of the roots of Paeonia lactiflora Pall., Paeoniaceae, Glycyrrhiza glabra L., Fabaceae, and Aconitum carmichaelii Debx., Ranunculaceae, exhibits an anti-inflammatory and analgesic effects. However, pharmacokinetic studies of its potential active ingredients have rarely been studied. The aim of present study was to characterize the pharmacokinetic properties of albiflorin, paeoniflorin, benzoylmesaconine, liquiritin, liquiritigenin, glycyrrhizic acid, and glycyrrhetinic acid after administration of the Shaoyao-Gancao-Fuzi decoction in rat. The plasma concentrations of the seven active components were analyzed by liquid chromatography coupled to mass spectrometry with a good accuracy (87.62–109.71%), precision (2.96–11.38%), extract recovery (85.79–103.68%), matrix effect (90.38–107.77%), and stability (86.66–112.75%). As results, albiflorin, paeoniflorin, and benzoylmesaconine were rapidly absorbed with Tmax < 1 h and slowly eliminated with mean half-life of 6.22–7.11 h. Glycyrrhetinic acid exhibited a high bioavailability. Graphical abstract | ||
650 | 4 | |a Paeoniflorin |7 (dpeaa)DE-He213 | |
650 | 4 | |a Glycyrrhetinic acid |7 (dpeaa)DE-He213 | |
650 | 4 | |a Benzoylmesaconine |7 (dpeaa)DE-He213 | |
650 | 4 | |a Pharmacokinetics |7 (dpeaa)DE-He213 | |
650 | 4 | |a LC-MS/MS |7 (dpeaa)DE-He213 | |
700 | 1 | |a Wang, Yuan |e verfasserin |4 aut | |
700 | 1 | |a Shao, Sennan |e verfasserin |4 aut | |
700 | 1 | |a Lin, Wen |e verfasserin |4 aut | |
700 | 1 | |a Huang, Dan |e verfasserin |4 aut | |
700 | 1 | |a Pan, Ronghua |e verfasserin |4 aut | |
700 | 1 | |a Xia, Yufeng |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Revista Brasileira de farmacognosia |d Critiba : Soc. Brasileira de Farmacognosia, 1986 |g 30(2020), 6 vom: Dez., Seite 810-817 |w (DE-627)SPR039332519 |w (DE-600)2690840-2 |x 1981-528X |7 nnns |
773 | 1 | 8 | |g volume:30 |g year:2020 |g number:6 |g month:12 |g pages:810-817 |
856 | 4 | 0 | |u https://dx.doi.org/10.1007/s43450-020-00119-0 |z lizenzpflichtig |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_SPRINGER | ||
912 | |a SSG-OLC-PHA | ||
912 | |a SSG-OPC-PHA | ||
912 | |a SSG-OPC-ASE | ||
951 | |a AR | ||
952 | |d 30 |j 2020 |e 6 |c 12 |h 810-817 |